• 1
    Kuo G, Choo QL, Alter HJ, Redeker AG, Purcell RH. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 2624.
  • 2
    Chiaramonte M, Stroffolini T, Caporaso N, et al. Hepatitis C virus infection in Italy: a multicentric seroepidemiological study. Ital J Gastroenterol 1991; 23: 5558.
  • 3
    Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med 1993; 86(2): 11925.
  • 4
    Stroffolini T, Menchinelli M, Taliani G, et al. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Ital J Gastroenterol 1995; 27: 2358.
  • 5
    Marcellin P, Benhamou JP. Natural history of hepatitis C virus infection. Pathol Biol Paris 1995; 43(8): 66973.
  • 6
    Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 1996; 24(3): 2716.
  • 7
    Chien DY, Choo QL, Tabrizi A, et al. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: re-evaluation of the role of HCV in liver disease. Proc Natl Acad Sci USA 1992; 89: 1001115.
  • 8
    Stroffolini T, Chiaramonte M, Tiribelli C, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360.
  • 9
    Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969.
  • 10
    Van der Pael CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 14759.
  • 11
    Yoshimura E, Hayashi J, Yoshiki T, et al. Inverse correlation between the titre of antibody to hepatitis C virus and the degree of hepatitis C viremia. J Infect 1994; 29: 14755.
  • 12
    Bach N, Bodenheimer HC Jr. Transmission of hepatitis C: sexual, vertical or exclusively bloodborne Hepatology 1992; 16(6): 1497.
  • 13
    Galeazzi B, Tufano A, Barbierato E, Bortolotti F. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 1995; 15(4): 20912.
  • 14
    Rivanera D, Lilli D, Lormo D, et al. Detection of antibodies to hepatitis C virus in dialysis patients. Eur J Epidemiol 1993; 9(1): 55.
  • 15
    Marranconi F, Fabris P, Stecca C, et al. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 1994; 22: 3337.
  • 16
    Kusuya N. Epidemiological studies on hepatitis C virus infection: detection, prevalence, exposure and prevention. Intervirology 1994; 37: 5867.
  • 17
    Mele A. Sorveglianza epidemiologica dell'epatite virale acuta. Notiziario dell'Istituto Superiore di Sanità (SEIEVA). 1996; 9(suppl 7): 4.
  • 18
    Zanetti AR, Tanzi E, Romanò L, Mele A. Epidemiology and prevention of hepatitis type C in Italy. Res Virol 1995; 146: 2539.
  • 19
    Esfahani RF, Sounders N. Ward KN, Hodgson HJF. The spectrum of hepatitis C antibody positive disease in a teaching hospital. J Infect 1995; 30: 11519.
  • 20
    Dixit V, Quan S, Martin P, et al. Evaluation of novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol 1995; 33: 297883.
  • 21
    Coppola R, Rizzetto M, Bradley DW. Viral hepatitis handbook. Ed. Crivelli O.Saluggia: Sorin Biomedica Diagnostics spA 1996: 7980.